Seema Dawood: Abnormal Nuclear Morphology of Neutrophil
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Abnormal Nuclear Morphology of Neutrophil
Hyposegmented neutrophils
Neutrophils with nuclei having only 1–2 lobes or appear unsegmented
Unsegmented nucleus:
- Round or oval nucleus with no segmentation
- Bilobed nucleus: Two-lobed nucleus, often resembling pince-nez glasses
Commonly found in:
- Pelger-Huët Anomaly (PHA) – Congenital
- Pseudo PelgerHuët Anomaly (PPHA) – Acquired (associated with bone marrow disorders , severe infections , drug-induced or certain types of leukemia)
Hypersegmented neutrophils
Neutrophils with nuclei having more than 5 lobes (especially more than 6).
The nuclear segmentation is excessive but orderly.
Commonly seen in:
- Megaloblastic Anemia (e.g., Vitamin B12 or Folate deficiency)
- Myelodysplastic Syndromes
- Chemotherapy induced bone marrow suppression
Botryoid neutrophils
Neutrophils with multiple nuclear lobes arranged in a radial pattern, often connected by interchromatin bridges.
The nuclei resemble a ‘grape-like cluster’ (botryoid means grape-like).
Commonly observed in:
- Hyperthermia
- Heatstroke
- Severe bacterial infections
- Extensive burns
- Severe inflammatory responses
- Uremia (kidney failure)
- Chemotherapy or drug toxicity
- May also be observed in hematologic malignancies such as leukemia or myelodysplastic syndrome (MDS)
The presence of Botryoid Neutrophils is considered a warning sign that ‘the body is experiencing a serious pathological condition or critical systemic stress, particularly involving the immune system, severe infections, toxic states, or hematologic disorders.'”
See more in the gallery.
Other posts featuring Seema Dawood on Hemostasis Today.
-
Jul 4, 2026, 12:47Panagiota Tsiatsiou: Tissue Factor Biomarkers Reveal Persistent Procoagulant Activity During Combined Androgen Blockade in Prostate Cancer
-
Jul 4, 2026, 12:34Omar Adwan: Are You Following Proper Phlebotomy Technique?
-
Jul 4, 2026, 12:24Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
-
Jul 4, 2026, 12:04Lara Bloom: Building Momentum for Rare Diseases
-
Jul 4, 2026, 11:52Heghine Khachatryan: A Valuable Educational Resource on Inhibitor Development
-
Jul 4, 2026, 11:42Roshni Kulkarni: Study Underscores the Urgent Need to Prevent Postpartum Hemorrhage Deaths
-
Jul 4, 2026, 11:25Michael Cahillane: Latest Transfusion Medicine Research Takes Center Stage at ISBT Congress
-
Jul 4, 2026, 11:10Henning Nilius: Career Milestone Reached with FAMH Specialist Certification
-
Jul 4, 2026, 10:56Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies